...
【24h】

Mechanisms of metastasis as related to receptor tyrosine kinases in small-cell lung cancer.

机译:与小细胞肺癌中受体酪氨酸激酶相关的转移机制。

获取原文
获取原文并翻译 | 示例
           

摘要

Small-cell lung cancer (SCLC) is an aggressive, malignant neoplasm with a 5-year survival of less than 10%. This poor survival rate is related to a high propensity for recurrence and a high rate of metastases. Metastases initially occur in the lymph nodes and thereafter in other organs such as the lung itself, liver, adrenal glands, brain, bone, and bone marrow. The mechanisms of metastases have been better understood recently and are described in this review. Receptor tyrosine kinases (RTKs) have been identified as important therapeutic targets in non-small-cell lung cancer (such as the EGF-receptor). We have begun to identify RTKs in SCLC and have shown that c-Kit and c-Met are expressed and functional in SCLC. RTKs have also been shown to be important in the metastasis of cancer cells. The roles of RTKs in the mechanism of metastasis are detailed in this review, with special emphasis on downstream signal transduction from RTK signaling.
机译:小细胞肺癌(SCLC)是一种侵袭性,恶性肿瘤,其5年生存率不到10%。这种差的存活率与复发的倾向高和转移率高有关。转移最初发生在淋巴结中,然后发生在其他器官,例如肺本身,肝脏,肾上腺,脑,骨骼和骨髓中。最近已经更好地了解了转移的机制,并在本综述中进行了描述。受体酪氨酸激酶(RTK)已被确定为非小细胞肺癌(例如EGF受体)的重要治疗靶标。我们已经开始鉴定SCLC中的RTK,并且已经证明c-Kit和c-Met在SCLC中表达并起作用。还已经显示RTK在癌细胞转移中很重要。本文综述了RTK在转移机制中的作用,尤其着重于RTK信号转导的下游信号转导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号